Publisher of the most cited open-access journals in their fields.
The section Hypertension welcomes articles on key findings of basic and clinical aspects of blood pressure regulation, both systemic and in the pulmonary vascular bed, as well as novel data on genetic features, molecular mechanisms, pathophysiology, diagnosis, and treatment of high blood pressure.
Frontiers in Cardiovascular Medicine is a global, peer-reviewed Open Access medical journal providing unrestricted, online access to publications on diagnostic and therapeutic advances in cardiology and cardiovascular disease. Frontiers in Cardiovascular Medicine publishes peer-reviewed scientific investigations of the highest quality that are of relevance for the diagnosis, treatment, or pathogenesis of cardiovascular disease and related disorders with the goal to understand disease processes and to improve medical practice and patient care.
The specialty section Hypertension is devoted to publishing reviews, commentaries, position papers, and high-rank research in the field of the most prevalent cardiovascular risk factors, e.g. high blood pressure.
In the past forty years the investigation of the mechanisms regulating blood pressure has been instrumental for improving our understanding of cardiovascular pathophysiology at large. This has led to a flood of knowledge with enormous implications for several other cardiovascular diseases, including heart failure, atherosclerosis, cardiovascular hypertrophy, and tissue fibrosis. Unfortunately, often the publication of relevant new findings has been hampered and/or delayed by a number of factors, and some important studies eventually did not get published. We intend to overcome these difficulties by ensuring an unbiased and swift assessment of all submitted manuscripts.
Hence, we encourage submissions reporting key findings on basic and clinical aspects of regulation of blood pressure, both systemic and in the pulmonary vascular bed, as well as novel data on the genetic features, molecular mechanisms, epidemiology, pathophysiology, diagnosis, and treatment of high blood pressure. Particular attention will be devoted to studies reporting on the mechanisms leading to cardiovascular damage and the triggering of cardiovascular and cerebrovascular events.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.
Indexed in: PubMed, PubMed Central, Google Scholar, DOAJ, CrossRef, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS
PMCID: all published articles receive a PMCID
Hypertension welcomes submissions of the following article types: Case Report, Clinical Study Protocol, Correction, Editorial, General Commentary, Mini Review, Opinion, Original Research, Perspective, Review and Systematic Review.
All manuscripts must be submitted directly to the section Hypertension, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Hypertension will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cardiovascular Medicine.